Insider Buying: Citigroup Inc. (NYSE:C), American Realty Capital Properties (NASDAQ:ARCP), Inovio Pharmaceuticals (NYSEMKT:INO), Sears Holdings (NASDAQ:SHLD)

Citigroup (NYSE:C) CEO Barbara Desoer bought 1,000 shares of the company’s stock on the open market in a transaction that occurred on Tuesday, April 15th. The shares were purchased at an average price of $48.19 per share, for a total transaction of $48,190.00. Following the completion of the transaction, the chief executive officer now directly owns 1,000 shares in the company, valued at approximately $48,190. Citigroup Inc. (NYSE:C) shares after opening at $48.18 moved to $48.22 on last trade day and at the end of the day closed at $47.84. Company price to sales ratio in past twelve months was calculated as 2.33 and price to cash ratio as 0.19. Citigroup Inc. (NYSE:C) showed a positive weekly performance of 4.73%.

American Realty Capital Properties (NASDAQ:ARCP) Director Edward M. Jr. Weil bought 7,500 shares of the company’s stock on the open market in a transaction dated Monday, April 21st. The shares were purchased at an average price of $13.28 per share, with a total value of $99,600.00. Following the completion of the acquisition, the director now directly owns 5,086 shares in the company, valued at approximately $67,542. American Realty Capital Properties Inc. (NASDAQ:ARCP) shares advanced 0.53% in last trading session and ended the day on $13.36. ARCP return on equity ratio is recorded as -31.80% and its return on assets is -11.90%. American Realty Capital Properties Inc. (NASDAQ:ARCP) yearly performance is -13.58%.

Inovio Pharmaceuticals (NYSE:INO) CEO Jong Joseph Kim purchased 25,000 shares of the stock in a transaction dated Tuesday, April 15th. The stock was purchased at an average cost of $2.25 per share, for a total transaction of $56,250.00. Following the completion of the acquisition, the chief executive officer now directly owns 5,965,809 shares in the company, valued at approximately $13,423,070. Inovio Pharmaceuticals Inc. (NYSEMKT:INO) shares moved up 1.98% in last trading session and was closed at $2.57, while trading in range of $2.50 – $2.62. Inovio Pharmaceuticals Inc. (NYSEMKT:INO) year to date (YTD) performance is -11.38%.

Sears Holdings Corp. (NASDAQ:SHLD) Director Thomas Tisch bought 475,000 shares of the stock on the open market in a transaction that occurred on Wednesday, April 16th. The stock was purchased at an average cost of $33.56 per share, for a total transaction of $15,941,000.00. Sears Holdings Corp (NASDAQ:SHLD) weekly performance is 21.40%. On last trading day company shares ended up $39.60. Sears Holdings Corp (NASDAQ:SHLD) distance from 50-day simple moving average (SMA50) is 10.81%. Analysts mean target price for the company is $20.00.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *